For this quarter, Wall Street analysts forecast UnitedHealth Group Incorporated (UNH) revenue in a range of $57.08 billion to $58.86 billion, which should be compared with $56.89 billion generated last year. EPS is seen in a range of $3.16 to $3.38, against the $2.77 reported a year ago.The shares have gained 10% since the company’s last earnings report. Over the past 12 fiscal quarters, UnitedHealth Group Incorporated (NYSE:UNH) has topped consensus earnings estimates in 12 quarters (100%), missed earnings in 0 quarters (0%), whereas at 0 occasion EPS met analyst expectations. UNH last reported earnings on October 16, 2018 when it released Sep-18 results that exceeded expectations. The company raked in $3.41 per share, -4.48% change on the same period last year. That was better than consensus for $3.29. Revenue for the recent quarter stood at $56.56 billion, up 12% on last year and above the $56.35 billion predicted by analysts.
UNH’s 50 day simple moving average (SMA 50) price is $267.04 and its 200-day simple moving average (SMA 200) price is $250.55. The company’s stock currently has a total float of 954.92M shares. Its weekly volatility is hovering around 2.46% and felt 2.17% volatility in price over a month. On the upside, the share price will test short term resistance at around $285.36. On a downside, the stock is likely to find some support, which begins at $274.33. The failure to get near-term support could push it to $270.1.
Separately, it has been reported that multiple insider activity took place at UnitedHealth Group Incorporated (UNH). Director Burke Richard T sold 6,090 shares for $1,797,584 in transaction occurred on 2018/11/28. After making this transaction, the Director owns a direct stake of 1,715,675 shares, worth $501,000,000, as per the last closing price. On 2018/11/28 Wilensky Gail R, Director at UNH, dumped 5,880 shares at an average price of $279.77 per share. The selling total is valued at $16,558,126.
Director, Shine Kenneth Irwin had divested 163 shares for $29,153 through a trade on 2018/11/09. Following this activity, the insider holds 44,797 shares worth $8,120,568 as of recent close. Wall Street’s most bullish UnitedHealth Group Incorporated (NYSE:UNH) analysts are predicting the share price to blow past $335 per share during the next 12 months. The current median share price forecast by them is $308, suggesting that the stock could increase 10.57% in that time frame. The average price target of $305.43 calls for a nearly 9.65% increase in the stock price.
It had seen a negative analyst call from Citigroup, which downgraded the stock from Buy to Neutral on September 10. Analysts at SunTrust, started covering the stock on June 11 with a Buy rating. Analysts at Barclays, made their first call about the stock on March 08, recommending it is Overweight. Citigroup, reiterated their call for Buy, on January 17. On the other hand, they had set new target price to $268 versus $235.
When looking at valuations, UnitedHealth Group Incorporated (UNH) has a pricey P/E of 24.16x as compared to industry average of 23.14x. Moreover, it trades for 18.95 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 5.36x price/book and 1.22x price/sales. Compared to others, UnitedHealth Group Incorporated is in a different league with regards to profitability, having net margins of 5.7%. To put some perspective around this, the industry’s average net margin is 3.87%. UNH’s ROE is 26%, which is also considerably better than the industry’s ROE of 16.79%.
UnitedHealth Group Incorporated (NYSE:UNH) shares went down -2.72% in Tuesday’s session, putting the price tag at $278.55 plus $269.11B in market capitalization. Earlier in the session, the stock traded between $276.91 and $287.94. Trading activity significantly improved as the volume at ready counter increased to 4,569,343 shares versus 3,750,770 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 3,195,190 shares. The stock is now 33.61% above against its bear-market low of $208.48 on February 05, 2018. It has retreated -3.37% since it’s 52-week high of $287.94 reached in December. Now the market price is up 25.8% on the year and up 26.35% YTD.